IndiaMTF — home
Stock

CIPLA

Cipla Limited
Health Technology

Daily Margin Trading Facility book for CIPLA across NSE and BSE, from 01 Jan 2025. All figures in ₹ crore, derived from exchange public disclosures.

Funded value
₹98 Cr
as of 10 Sep 2026
Rank in book
#390
378 days tracked
Share of book
0.06%
of the whole NSE + BSE book
Peak funded
₹143 Cr
on 06 Nov 2025
Largest single-day addition
+₹41 Cr
on 07 Jan 2026
Largest single-day unwind
−₹26 Cr
on 25 Jul 2025

NSE & BSE split

How CIPLA’s funded book divides across the two exchanges, as of 10 Sep 2026.
NSE
NSE ₹95 Cr · 96.1%BSE ₹4 Cr · 3.9%

MTF vs Price

Margin-funded outstanding for CIPLA in ₹ crore against the closing price, adjusted for splits and bonuses. Each window uses the same reference date as the table below, so the two agree. Funded value moves with the price on its own, so the line under the chart reads the share count instead — that is what shows whether more stock is genuinely being borrowed against.
MTF book (₹ Cr)

Price and liquidity

Adjusted for splits and bonuses, so a change across a corporate action reflects the market rather than the share count.
Last close
₹1,366.00
as of 11 Sep 2026
Price, 30 days
−7.3%
adjusted for splits and bonuses
Delivery, 20-day avg
54.7%
of traded volume actually settled
Sessions to unwind
1.6
of average deliverable volume
Shares under margin divided by average daily deliverable volume over the last 20 sessions.

Book, shares and price by window

Funded value moves with the price on its own, so the share count is what shows whether more stock is actually being borrowed against. The last column reads the two together.
WindowBook ΔBook %SharesPriceReading
1 day−₹0−0.5%−0.5%
−3,517
+0.7%unwinding into strength
10 days+₹4+4.1%+4.7%
+30,465
−3.3%building as it falls
30 days+₹28+40.6%+42.0%
+1,99,797
−6.3%building as it falls
90 days+₹15+17.7%+17.4%
+1,00,348
−1.2%building as it falls
180 days−₹18−15.6%−15.0%
−1,19,431
+3.6%unwinding into strength
1 year+₹30+44.1%+39.0%
+1,89,482
−9.1%building as it falls
Price is as of 11 Sep 2026; the MTF book is as of 10 Sep 2026. Exchanges publish the margin file a day after the market data, and the comparison above uses the MTF date for both sides.

Shares under margin

Number of shares funded via MTF over time (NSE + BSE combined).

Rank trajectory

Where CIPLA has sat in the funded-value ranking each day (1 = most funded). Lower is more prominent.

CIPLA — last 30 trading days

Combined NSE + BSE funded value, day-on-day change, share of the whole book, and rank. Newest first.
DateCombined (₹ Cr)Day Δ (₹ Cr)% of bookRank
10 Sep 202698−₹00.06%390
09 Sep 202699+₹10.06%385
08 Sep 202698−₹40.06%391
07 Sep 2026102−₹10.07%372
04 Sep 2026103+₹20.07%369
03 Sep 2026101+₹40.07%368
02 Sep 202697+₹40.06%383
01 Sep 202693+₹00.06%404
31 Aug 202693−₹00.06%401
28 Aug 202693−₹10.06%397
27 Aug 202694−₹10.06%389
26 Aug 202696+₹30.06%387
25 Aug 202692+₹40.06%399
24 Aug 202689+₹00.06%409
21 Aug 202688+₹10.06%411
20 Aug 202687−₹10.06%413
19 Aug 202688+₹00.06%411
18 Aug 202687+₹20.06%408
17 Aug 202686+₹40.06%421
14 Aug 202682+₹10.06%435
13 Aug 202681+₹00.06%441
12 Aug 202681+₹10.06%446
11 Aug 202680+₹00.06%449
10 Aug 202680+₹00.06%454
07 Aug 202679+₹20.06%445
06 Aug 202677+₹30.05%456
05 Aug 202674+₹10.05%470
04 Aug 202673+₹30.05%471
03 Aug 202670+₹00.05%489
31 Jul 202669—0.05%482

CIPLA within Health Technology

Ranked #21 of 61 funded Health Technology stocks, carrying 1.5% of that sector’s margin book. Nearest names by funded value:
#StockMTF book (₹ Cr)% of sector
19MANKIND
Mankind Pharma Limited
₹1001.6%
20ACUTAAS
Acutaas Chemicals Limited
₹1001.6%
21CIPLA
Cipla Limited
₹981.5%
22NEULANDLAB
Neuland Laboratories Limited
₹841.3%
23ANTHEM
Anthem Biosciences Limited
₹771.2%

All Health Technology stocks and how the sector has moved →

Disclaimer. Data sourced from daily margin trading disclosure provided by NSE and BSE. This website and page are meant for educational and information only — not investment advice. MTF is leveraged and can amplify losses. Rules, margins, rates and eligible-stock lists change; verify current details with your broker and SEBI/exchange circulars. IndiaMTF.com is not a SEBI-registered intermediary, broker, or investment adviser and has no affiliation with SEBI, NSE or BSE. Figures are reproduced from publicly disclosed exchange data, may be delayed or revised, and should be independently verified before any trading decision. Consult a SEBI-registered investment adviser before investing.